Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

6
results for

"Paracentesis"

Article category

Keywords

Publication year

"Paracentesis"

Review

Liver fibrosis, cirrhosis, and portal hypertension

Management of refractory ascites
Florence Wong
Clin Mol Hepatol 2023;29(1):16-32.
Published online June 9, 2022
DOI: https://doi.org/10.3350/cmh.2022.0104
The development of refractory ascites in approximately 10% of patients with decompensated cirrhosis heralds the progression to a more advanced stage of cirrhosis. Its pathogenesis is related to significant hemodynamic changes, initiated by portal hypertension, but ultimately leading to renal hypoperfusion and avid sodium retention. Inflammation can also contribute to the pathogenesis of refractory ascites by causing portal microthrombi, perpetuating the portal hypertension. Many complications accompany the development of refractory ascites, but renal dysfunction is most common. Management starts with continuation of sodium restriction, which needs frequent reviews for adherence; and regular large volume paracentesis of 5 L or more with albumin infusions to prevent the development of paracentesisinduced circulatory dysfunction. Albumin infusions independent of paracentesis may have a role in the management of these patients. The insertion of a covered, smaller diameter, transjugular intrahepatic porto-systemic stent shunt (TIPS) in the appropriate patients with reasonable liver reserve can bring about improvement in quality of life and improved survival after ascites clearance. Devices such as an automated low-flow ascites pump may be available in the future for ascites treatment. Patients with refractory ascites should be referred for liver transplant, as their prognosis is poor. In patients with refractory ascites and concomitant chronic kidney disease of more than stage 3b, assessment should be referred for dual liver-kidney transplants. In patients with very advanced cirrhosis not suitable for any definitive treatment for ascites control, palliative care should be involved to improve the quality of life of these patients.

Citations

Citations to this article as recorded by  Crossref logo
  • Outcomes following nurse-led day-case paracentesis
    Mahir Yousuff, Pramudi Wijayasiri, Renee Ma, Rabiat Umar, Ripak Purbe, Nicola J. Monahan, Helen L. Garrity, Beverley J. Aram, Naaventhan Palaniyappan, Emilie Wilkes, Aloysious D. Aravinthan
    Clinical Medicine.2026; 26(1): 100538.     CrossRef
  • Integrated analysis of gut microbiota structure and metabolic function in patients with cirrhosis and refractory ascites
    Dianyan Chen, Sandu Liu, Ka Zhang, Ke Pan, Linsu Zhang, Deyun Shu, Jin Zhang, Dingyao Ren
    Biomedical Reports.2026; 24(2): 1.     CrossRef
  • Splenic Artery Embolization for Refractory Ascites Following Hepatectomy for Hepatocellular Carcinoma
    Abdeali Saif Arif Kaderi, Shraddha Patkar, Nitin S Shetty, Kunal B Gala, Suyash Kulkarni, Mahesh Goel
    Indian Journal of Surgical Oncology.2026; 17(4): 728.     CrossRef
  • Marked effect of topical application of Chinese medicine combined with moxibustion in a case of refractory malignant ascites in diffuse liver cancer
    Dou-dou Feng, Xing-ping Zhang, Lei Guo, Chuan He
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Direct venous‑to‑arterial communication as a novel mechanism for ectopic embolism following esophageal variceal embolization: A case report
    Youchun Lei, You Ke, Tianwen Yang, Zhengguo Xu
    Experimental and Therapeutic Medicine.2026; 31(5): 1.     CrossRef
  • Elective Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis Improves Body Composition and Function: Pilot Randomized Trial—Commentary
    Hector Ferral
    CardioVascular and Interventional Radiology.2026; 49(6): 1163.     CrossRef
  • Proximal splenic artery embolization for treatment of refractory ascites, a single‐center experience
    Abdul Rehman Mustafa, Raneem Atta, Russell P. Goodman, Vincent Wu, Zubin Irani, Omar Zurkiya, Emily D. Bethea, Kei Yamada, Eric P. Wehrenberg‐Klee
    Hepatology Research.2025; 55(2): 219.     CrossRef
  • Sex Differences in Patient-Reported Outcomes and Perception of Ascites Burden Among Outpatients With Decompensated Cirrhosis and Ascites
    Florence Wong, K. Rajender Reddy, Puneeta Tandon, Jennifer C. Lai, Guadalupe Garcia-Tsao, Jacqueline G. O'Leary, Scott W. Biggins, Hugo E. Vargas, Leroy Thacker, Patrick S. Kamath, Jasmohan S. Bajaj
    American Journal of Gastroenterology.2025; 120(8): 1791.     CrossRef
  • Midodrine and Weekly Albumin Therapy in Patients With Cirrhosis and Diuretic Intractable or Recurrent Ascites: A Case-Control Study
    Gourav J Borah, Gaurav Pande, Sayan Malakar, S Rakesh Kumar, Rajanikant R Yadav, Samir Mohindra
    Cureus.2025;[Epub]     CrossRef
  • The use of virtual reality-assisted interventions on psychological well-being and treatment adherence among kidney transplant recipients: A randomized controlled study
    Chao Zhong, Lin Yao, Lanlan Chen, Xiaofen Wang, Xiaohui Zhu, Yihong Wen, Lei Deng, Jiafu Chen, Jialiang Hui, Lisha Shi, Lijuan You
    Acta Psychologica.2025; 253: 104700.     CrossRef
  • Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump
    Sarah L. Schütte, Anja Tiede, Jim B. Mauz, Hannah Rieland, Martin Kabelitz, Robin Iker, Nicolas Richter, Bernhard Meyer, Benjamin Heidrich, Heiner Wedemeyer, Benjamin Maasoumy, Tammo L. Tergast
    Hepatology Communications.2025;[Epub]     CrossRef
  • Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter study
    Martin A. Kabelitz, Lukas Hartl, Golda Schaub, Anja Tiede, Hannah Rieland, Andrea Kornfehl, Peter Hübener, Mathias Jachs, Jan Hinrichs, Sarah L. Schütte, Christoph Riedel, Jim B. Mauz, Tammo L. Tergast, Bernhard C. Meyer, Peter Bannas, Julia Kappel, Heine
    Hepatology.2025; 82(5): 1172.     CrossRef
  • The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory Ascites
    Florence Wong, Hugo E. Vagas, K. Rajender Reddy, Mangesh R. Pagadala, Christine Pocha, Vinay Sundaram, Jasmohan S. Bajaj, Eran Shlomovitz, Emily Bendel, Jeroen Capel, Patrick S. Kamath
    American Journal of Gastroenterology.2025; 120(10): 2291.     CrossRef
  • Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites
    Shi-Hua Luo, Hui-Fang Zhang, Wei Liu, Jian-Guo Chu, Jian-Yong Chen
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Reinfusion of Malignant Ascites through an Extracorporeal Peritoneal Venous Shunt to Avoid Complications and Assess the Safety of a Denver Shunt: A Case Report
    Keisuke Baba, Tomoki Tanie, Yasuo Matsubara, Yoshihiro Hirata, Hiroaki Ikematsu, Narikazu Boku
    Case Reports in Oncology.2025; 18(1): 286.     CrossRef
  • Pharmacological Treatment of Ascites: Challenges and Controversies
    Jimmy Che-To Lai, Junlong Dai, Lilian Yan Liang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
    Pharmaceuticals.2025; 18(3): 339.     CrossRef
  • A model predicting the 6-year all cause mortality of patients with advanced schistosomiasis after discharge: Derived from a large population-based cohort study
    Lanyue Pan, Chunmei Wu, Ping Li, Jiaquan Huang, Yizhi Wu, Guo Li, Aysegul Taylan Ozkan
    PLOS Neglected Tropical Diseases.2025; 19(5): e0013134.     CrossRef
  • Investigation of bending angle algorithm and path planning for puncture needles in transjugular intrahepatic portosystemic shunt
    Qinmei Liao, Bing Li, Xihao Hu, Xiaoyun Huang, Jiacheng Guo, Yuanzhong Zhu, Wenjing He
    BioMedical Engineering OnLine.2025;[Epub]     CrossRef
  • Sodium-Glucose Cotransporter 2 Inhibitors for Patients With Cirrhosis Taking Diuretics—A Promising Step Toward Fewer Serious Liver Events
    Mohamed I. Elsaid
    JAMA Network Open.2025; 8(6): e2518478.     CrossRef
  • Jabor A., Březina A.: Analysis od less common body fluids: Part 2 - peritoneal fluid and ascites
    A Jabor, A Březina
    Klinická biochemie a metabolismus.2025; 33(2): 34.     CrossRef
  • TIPS in Patients With Refractory Ascites: Review of Literature and Current Recommendations
    Matthew Abad-Santos, James Jeffries, Charles Hua, Guy E. Johnson
    Techniques in Vascular and Interventional Radiology.2025; : 101057.     CrossRef
  • Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites
    Maha Elsabaawy, Mohammed Ragab, Madiha Naguib, Eman Kamal, Maymona Al-Khalifa, Khaled Gamil, Marwa Elfayoumy
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites
    Jasmohan S. Bajaj, Ethan M. Weinberg, K. Rajender Reddy, Andrew P. Keaveny, Michael K. Porayko, David Koch, Paul J. Thuluvath, Douglas A. Simonetto, Paolo Angeli, Sujit V. Janardhan, Eric S. Orman, Jeffrey Zhang, Susan Clausen, Elisa Dauphinée, Joseph M.
    Liver Transplantation.2025; 31(10): 1202.     CrossRef
  • Refractory Ascites in Patients With Cirrhosis
    Madhumita Premkumar
    JGH Open.2025;[Epub]     CrossRef
  • Future research direction of portal hypertension based on Baveno VII
    Xuefeng Luo, Guangchuan Wang, Li Yang, Virginia Hernandez-Gea
    Chinese Medical Journal.2025; 138(18): 2268.     CrossRef
  • New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target
    Yunqi Xing, Yanghao Ou, Yujie Wang, Luming Hou, Junfeng Zhu
    Biochemical Pharmacology.2025; 242: 117284.     CrossRef
  • Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach
    Mario Romeo, Carmine Napolitano, Paolo Vaia, Fiammetta Di Nardo, Silvio Borrelli, Carlo Garofalo, Luca De Nicola, Alessandro Federico, Marcello Dallio
    Livers.2025; 5(3): 46.     CrossRef
  • Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models
    Julian Müller-Kühnle, Moritz Schanz, Severin Schricker, Christian Benignus, Julia Todoroff, Jörg Latus, Wolfram Zoller, Dominik Marschner, Zhaoqing Du
    PLOS One.2025; 20(9): e0332840.     CrossRef
  • Decompensated cirrhosis but low MELD—Should we wait or refer for liver transplantation?
    Noreen Singh, Yu Jun Wong, Patrizia Burra, Nazia Selzner, Aldo J. Montano-Loza
    Liver Transplantation.2025; 31(11): 1423.     CrossRef
  • Management of intractable ascites in cirrhosis: a review article
    I. Dewa Ayu Made Dian Lestari, Ketut Suryana
    International Journal of Advances in Medicine.2025; 13(1): 56.     CrossRef
  • Acute kidney injury after TIPS in decompensated cirrhosis patients: a retrospective cohort study
    Meng Jia, Yi-Dan Guo, Peng-Peng Ye, Xiao-Ling Zhou, Yang Luo
    BMC Nephrology.2025;[Epub]     CrossRef
  • Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
    Mark W Sonderup, Patrick S Kamath, Yaw A Awuku, Hailemichael Desalegn, Neliswa Gogela, Leolin Katsidzira, Christian Tzeuton, Bilal Bobat, Chris Kassianides, C Wendy Spearman
    The Lancet Gastroenterology & Hepatology.2024; 9(2): 170.     CrossRef
  • Recent developments in the management of ascites in cirrhosis
    Tian Lan, Ming Chen, Chengwei Tang, Pierre Deltenre
    United European Gastroenterology Journal.2024; 12(2): 261.     CrossRef
  • A new strategy for the treatment of refractory ascites in patients with hepatitis B-related liver cirrhosis
    Wenjing Xu, Gang Wang
    Asian Journal of Surgery.2024; 47(6): 2761.     CrossRef
  • Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis
    Shingo Koyama, Asako Nogami, Masato Yoneda, Shihyao Cheng, Yuya Koike, Yuka Takeuchi, Michihiro Iwaki, Takashi Kobayashi, Satoru Saito, Daisuke Utsunomiya, Atsushi Nakajima
    Tomography.2024; 10(4): 471.     CrossRef
  • Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
    Danielle Adebayo, Florence Wong
    Alimentary Pharmacology & Therapeutics.2024; 59(10): 1196.     CrossRef
  • Treatment of portal hypertension complicated by variceal bleeding
    M.I. Tutchenko, D.V. Rudyk, І.V. Klyuzko, M.S. Besedinskyi, S.L. Chub, О.А. Sirenko
    EMERGENCY MEDICINE.2024; 20(3): 180.     CrossRef
  • External treatment of refractory ascites induced by liver cirrhosis using traditional Chinese medicine
    Xuerong Wang, Xiaoqin Zeng, Gang Wang
    Asian Journal of Surgery.2024; 47(10): 4429.     CrossRef
  • Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension
    Laura Büttner, Lisa Pick, Martin Jonczyk, Uli Fehrenbach, Federico Collettini, Timo Alexander Auer, Dirk Schnapauff, Maximilian De Bucourt, Gero Wieners, Bernhard Gebauer, Annette Aigner, Georg Böning
    Insights into Imaging.2024;[Epub]     CrossRef
  • Advancements in ascites management: a comprehensive narrative review of the Alfa Pump system
    Muhammad Asim, Nabiha Naqvi, Vikash Kumar Karmani, Aima Tahir, Umm E. Salma Shabbar Banatwala, Shahzeb Rehman, Minha Aslam, Aleena Majeed, Farhan Khan
    Egyptian Liver Journal.2024;[Epub]     CrossRef
  • Drainage of ascites in cirrhosis
    Jia-Xing Yang, Yue-Ming Peng, Hao-Tian Zeng, Xi-Min Lin, Zheng-Lei Xu
    World Journal of Hepatology.2024; 16(9): 1245.     CrossRef
  • Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide
    Adonis A Protopapas, Alexandra Tsankof, Ioanna Papagiouvanni, Georgia Kaiafa, Lemonia Skoura, Christos Savopoulos, Ioannis Goulis
    World Journal of Hepatology.2024; 16(12): 1377.     CrossRef
  • A safe and effective treatment for refractory malignant ascites: the use of pigtail catheters
    Akif Doğan, Ömer Aydıner
    Polish Journal of Radiology.2024; 89: 561.     CrossRef
  • Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
    Tammo L. Tergast, Marie Griemsmann, Lena Stockhoff, Kerstin Port, Benjamin Heidrich, Markus Cornberg, Heiner Wedemeyer, Henrike Lenzen, Nicolas Richter, Elmar Jaeckel, Benjamin Maasoumy
    JAMA Network Open.2023; 6(7): e2322048.     CrossRef
  • Effect of different infusion approaches on safety and efficacy of terlipressin: Current controversies
    Yong He, Lu Chai, Han Chen, Xing-Shun Qi
    World Chinese Journal of Digestology.2023; 31(17): 705.     CrossRef
  • Evidence-based hyponatremia management in liver disease
    Ji Young Ryu, Seon Ha Baek, Sejoong Kim
    Clinical and Molecular Hepatology.2023; 29(4): 924.     CrossRef
  • Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
    Rahul Arya, Ramesh Kumar, Tarun Kumar, Sudhir Kumar, Utpal Anand, Rajeev Nayan Priyadarshi, Tanmoy Maji
    World Journal of Hepatology.2023; 15(10): 1140.     CrossRef
  • Pulmonary Complications in Patients with Liver Cirrhosis
    Seul Ki Han, Soon Koo Baik, Moon Young Kim
    The Korean Journal of Gastroenterology.2023; 82(5): 213.     CrossRef
  • Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade’s Literature Focusing on Incidence, Risk Factors, and Prophylaxis
    Karina Holm Friis, Karen Louise Thomsen, Wim Laleman, Sara Montagnese, Hendrik Vilstrup, Mette Munk Lauridsen
    Journal of Clinical Medicine.2023; 13(1): 14.     CrossRef
  • 23,254 View
  • 1,180 Download
  • 49 Web of Science
  • Crossref

Original Article

Liver fibrosis, cirrhosis, and portal hypertension

The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction
Maha Mohammad Elsabaawy, Shimaa Rashad Abdelhamid, Ayman Alsebaey, Eman Abdelsamee, Manar Abdelaal Obada, Tary Abdelhamid Salman, Eman Rewisha
Clin Mol Hepatol 2015;21(4):365-371.
Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.365
Background/Aims

Ascites is a dreadful complication of liver cirrhosis associated with short survival. Large volume paracentesis (LVP) is used to treat tense or refractory ascites. Paracentesis induced circulatory dysfunction (PICD) develops if no plasma expanders are given with ominous complications. To study the effect of ascites flow rate on PICD development.

Methods

Sixty patients with cirrhosis and tense ascites underwent LVP of 8 L were randomized into 3 equal groups of different flow rate extraction; group I (80 mL/minute), group II (180 mL/minute) and group III (270 mL/minute). Plasma renin activity (PRA) was measured baseline and on day six. PICD was defined as increase in PRA >50% of the pretreatment value.

Results

In group I through 3; the mean age was (52.5±9.4 vs. 56.4±8.5 vs. 55.8±7.1 years; P>0.05), mean arterial pressure (81.4±5.6 vs. 81.5±7 vs. 79.5±7.2 mmHg; P>0.05), MELD (17.6±4.1 vs. 15.8±4.1 vs. 14.7±4.5). Baseline PRA was comparable (1,366.0±1244.9 vs. 1,151.3±1,444.8 vs. 951.9±1,088 pg/mL; P>0.05). There was no statistically significant (P>0.05) flow mediated changes (Δ) of creatinine (0.23±0.27 vs. 0.38±0.33 vs. 0.26±0.18 mg/dL), MELD (1.25±5.72 vs. 1.70±2.18 vs. 1.45±2.21) or PRA (450.93±614.10 vs. 394.61±954.64 vs. 629.51±1,116.46 pg/mL). PICD was detected in a similar frequency in the three groups (P>0.05). On univariate logistic analysis only female sex was a fairly significant PICD predictor (Wald 3.85, odds ratio 3.14; P=0.05).

Conclusions

The ascites flow rate does not correlate with PICD development.

Citations

Citations to this article as recorded by  Crossref logo
  • Performance of Early Therapeutic Paracentesis in Spontaneous Bacterial Peritonitis and Its Effect on Clinical Outcomes
    Brian J. Wentworth, Mohammed Shwetar, Indika Mallawaarachchi, Sarah Ratcliffe, Mary McGrath, Laura Lavette, Anthony Rainho, Neeral Shah
    JGH Open.2026;[Epub]     CrossRef
  • Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial
    Hyung Joon Yim, Tae Hyung Kim, Sang Jun Suh, Sun Young Yim, Young Kul Jung, Yeon Seok Seo, Seong Hee Kang, Moon Young Kim, Soon Koo Baik, Hong Soo Kim, Young Seok Kim, Soo Young Park, Byung Ik Kim, Jun Yong Park, Jeong Heo, Joo Hyun Sohn, Nae-Yun Heo, Kwa
    American Journal of Gastroenterology.2023; 118(4): 654.     CrossRef
  • Use of laparocentesis in the treatment of ascites in patients with liver cirrhosis
    E. V. Mahiliavets, Y. N. Bozhko, O. N. Mahiliavets
    Proceedings of the National Academy of Sciences of Belarus, Medical series.2021; 18(3): 362.     CrossRef
  • Concordance of 24- and 48-h diagnostic follow-up ascitic fluid polymorphonuclear leukocyte count in the guidance of the antibiotic therapy in spontaneous bacterial peritonitis
    Hanaa Mostafa Badran, Maha Mohammad Elsabaawy, Mohamed Azazy Mahmoud, Heba Samy Ghanem, Ayman Alsebaey, Warda Othman
    Egyptian Liver Journal.2021;[Epub]     CrossRef
  • Clinical Progress Note: Intravenous Human Albumin in Patients With Cirrhosis
    Suchita Shah Sata, Omobonike Oloruntoba Sanders, Catherine A Curley
    Journal of Hospital Medicine.2021; 16(12): 738.     CrossRef
  • Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review
    Anand V Kulkarni, Pramod Kumar, Mithun Sharma, T R Sowmya, Rupjyoti Talukdar, Padaki Nagaraj Rao, D Nageshwar Reddy
    Journal of Clinical and Translational Hepatology.2020; 8(X): 1.     CrossRef
  • High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction
    Ayman Alsebaey, Eman Rewisha, Imam Waked
    Egyptian Liver Journal.2020;[Epub]     CrossRef
  • Paracentesis-induced circulatory dysfunction: are there albumin alternatives?
    Ayman Alsebaey, Eman Rewisha, Imam Waked
    Egyptian Liver Journal.2020;[Epub]     CrossRef
  • Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study
    Tae Hyung Kim, Yeon Seok Seo, Seong Hee Kang, Moon Young Kim, Sang Gyune Kim, Hyo Young Lee, Jeong‐Hoon Lee, Young‐Sun Lee, Ji Hoon Kim, Soung Won Jeong, Jae Young Jang, Ki Tae Suk, Young Kul Jung, Hyonggin An, Hyung Joon Yim, Young Seok Kim, Soon Ho Um
    Liver International.2020; 40(12): 3083.     CrossRef
  • Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N‐acetyl‐β‐D‐glucosaminidase
    Tae Hyung Kim, Han Ah Lee, Yeon Seok Seo, Yoo Ra Lee, Sun Young Yim, Young Sun Lee, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
    Journal of Gastroenterology and Hepatology.2019; 34(1): 234.     CrossRef
  • Current approaches to the management of patients with cirrhotic ascites
    Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
    World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
  • Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective
    J.F. Crismale, K.A. Meliambro, S. DeMaria, D.B. Bronster, S. Florman, T.D. Schiano
    American Journal of Transplantation.2017; 17(10): 2537.     CrossRef
  • What we know about paracentesis induced circulatory dysfunction?
    Jeong Han Kim
    Clinical and Molecular Hepatology.2015; 21(4): 349.     CrossRef
  • 14,649 View
  • 126 Download
  • 13 Web of Science
  • Crossref

Editorial

Liver fibrosis, cirrhosis, and portal hypertension

What we know about paracentesis induced circulatory dysfunction?
Jeong Han Kim
Clin Mol Hepatol 2015;21(4):349-351.
Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.349

Citations

Citations to this article as recorded by  Crossref logo
  • Serum sodium level is predictive for kidney injury or hyponatremia after modest-volume paracentesis (<5 L) in Asian patients with cirrhosis: A single-centered retrospective observational study
    Chayathorn Aramcharoen, Witchayaporn Praguylertluck, Naree Intarasak, Thanapon Yaowmaneerat, Apichat Kaewdech, Naichaya Chamroonkul, Pimsiri Sripongpun
    Medicine.2025; 104(6): e41420.     CrossRef
  • Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
    G. A. Ignatenko, T. E. Kugler, G. G. Taradin, I. V. Rakitskaya, A. A. Kaluga
    Safety and Risk of Pharmacotherapy.2022; 10(2): 161.     CrossRef
  • Step by Step: Managing the Complications of Cirrhosis
    Irene Perez, Fabian J Bolte, William Bigelow, Zachary Dickson, Neeral L Shah
    Hepatic Medicine: Evidence and Research.2021; Volume 13: 45.     CrossRef
  • Current approaches to the management of patients with cirrhotic ascites
    Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
    World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
  • The principles of management of patients with liver cirrhosis complicated by ascites
    Dmitry V. Garbuzenko
    Clinical Medicine (Russian Journal).2017; 95(9): 789.     CrossRef
  • 13,475 View
  • 175 Download
  • 4 Web of Science
  • Crossref

Case Report

Transcatheter coil embolization of the inferior epigastric artery in a huge abdominal wall hematoma caused by paracentesis in a patient with liver cirrhosis
Yun Ji Park, Sang Yeon Lee, Seong Hun Kim, In Hee Kim, Sang Wook Kim, Seung Ok Lee
Korean J Hepatol 2011;17(3):233-237.
Published online September 30, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.3.233

Therapeutic paracentesis is considered to be a relatively safe procedure and is performed commonly for the control of massive ascites in patients with liver cirrhosis. The commonest puncture site, approximately 4 or 5 cm medial of left anterior superior iliac spine, can be located across the route of the inferior epigastric artery, which is one of the sites of potential massive bleeding. In a 46-year-old woman with liver cirrhosis and refractory ascites, a huge abdominal wall hematoma developed after therapeutic paracentesis. The patient was not stabilized by conservative treatment, and inferior epigastric artery injury was confirmed on angiography. Angiographic coil embolization of the inferior epigastric artery was conducted, after which the bleeding ceased and the hematoma stopped growing. This case indicates that physicians performing paracentesis should be aware of the possibility of inferior epigastric artery injury and consider early angiographic coil embolization when a life-threatening abdominal wall hematoma develops.

Citations

Citations to this article as recorded by  Crossref logo
  • Abdominal wall hematoma related to subcutaneous low-molecular-weight heparin injection following coronary intervention therapy: case presentation
    Xiao-Hua LIU, Yi-Zhou XU
    Journal of Geriatric Cardiology.2025; 22(1): 214.     CrossRef
  • Successful Transcatheter Arterial Embolization of Abdominal Wall Hematoma from the Left Deep Circumflex Iliac Artery after Abdominal Paracentesis in a Patient with Liver Cirrhosis: Case Report and Literature Review
    Young Eun Seo, Chae June Lim, Jae Woong Lim, Je Seong Kim, Hyung Hoon Oh, Keon Young Ma, Ga Ram You, Chan Mook Im, Byung Chan Lee, Young Eun Joo
    The Korean Journal of Gastroenterology.2024; 83(4): 167.     CrossRef
  • Lights and Shadows of Paracentesis: Is an Ultrasound Guided Approach Enough to Prevent Bleeding Complications?
    Marta Patturelli, Luca Pignata, Pietro Venetucci, Maria Guarino
    Livers.2023; 3(1): 54.     CrossRef
  • Superselective Transcatheter Arterial Embolization of iatrogenic inferior epigastric artery after paracentesis: unusual manifestation of hemoperitoneum
    Tulio Fabiano De Oliveira Leite
    Journal of Hazardous Materials.2020; : 123578.     CrossRef
  • Superselective transcatheter arterial embolization of iatrogenic inferior epigastric artery after paracentesis
    Tulio Fabiano de Oliveira Leite
    International Journal of Surgery Case Reports.2020; 74(C): 32.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • Emergency Endovascular Hemostatic Technique Using N-butyl Cyanoacrylate for Retroperitoneal Hematoma Caused by Inferior Epigastric Artery Injury after Undergoing Catheter Ablation for Atrial Fibrillation: A Case Report
    Junya Tsurukiri, Eitaro Okumura, Hidefumi Sano, Mariko Moriya, Hiroshi Yamanaka, Keisuke Watanabe, Akira Hoshiai
    Journal of Neuroendovascular Therapy.2017; 11(12): 608.     CrossRef
  • Ultrasound-guided thrombin injection for treatment of superficial traumatic pseudoaneurysms and associated expanding hematomas: experience in five patients
    Sri Hari Sundararajan, Phillip Murillo, Adam Khan, Vyacheslav Gendel, Christopher Gribbin, Sudipta Roychowdhury, John Nosher
    Journal of Trauma Management & Outcomes.2016;[Epub]     CrossRef
  • Successful Coil Embolization of Circumflex Iliac Artery Pseudoaneurysms Following Paracentesis
    Ryan W. Day, Eric A. Huettl, Sailendra G. Naidu, William G. Eversman, David D. Douglas, Mark E. O’Donnell
    Vascular and Endovascular Surgery.2014; 48(3): 262.     CrossRef
  • A fatal complication of ultrasound‐guided abdominal paracentesis
    Matthew Seidler, Karl Sayegh, Anne Roy, Benoît Mesurolle
    Journal of Clinical Ultrasound.2013; 41(7): 457.     CrossRef
  • 10,316 View
  • 63 Download
  • Crossref
Original Articles
The Effect of Paracentesis on Pulmonary Function in Patients with Cirrhosis
Min Su Geum , Young Tak Kim , Sung Gon Choi , Chang Hyeong Lee , Young Oh Kweon , Sung Kook Kim , Yong Hwan Choi , Joon Mo Chung
Korean J Hepatol 1997;3(1):50-57.
Background/Aims
'. Paracentesis is an acceptable therapeutic modality for the symptomatic relief of dyspnea or abdominal fullness due to tense ascites in patients with cirrhosis. Whereas studies about the effects of paracentesis focused on the changes about hemodynamics, electrolytes and renal function in great detail, the effects of paracentesis on the changes about respiratory system have undergone limited investigations which are defined large-volume paracentesis. Methods .' We performed pulmonary function tests with arterial blood gas analysis just before and 24 hr after paracentesis. The paracentesis of average 2,300ml was carried out in ten liver cirrhosis patients with tense ascites who were free from underlying cardiopulmonary impairment. Results '. 1. The results of pulmonary function test just before paracentesis were as followings; FVC( functional vital capacity), FEV1(forced expiratory volume in 1 sec), FEF25 75(forced expiratory effort 25% 75%) and TLC(total lung capacity) were decreased as 78%, 79%, 62.3% and 89% of normal control value respectively, whereas RV(residual volume) was not decreased. DLCO(lung diffusion capacity of carbon monoxide)was decreased as 61.6%. 2. The results of pulmona function test 24 hr after paracentesis were as followings,' The symptomatic relief of dyspnea was achieved in all participated ten patients. Among lung volume parameters, FVC and VC were increased significantly(p=0.003, p=0.004). Whereas TLC was increased without statistical significance(p=0.228), and RV and FRC(functional residual capacity) showed no change. FEV1 was increased significantly(p=0.039), but FEF25 75 and the ratio of FEF1/FVC showed no change. DLCO was not increased. PaOy(partial pressure of oxygen in arterial blood) was impr'oved without statistical significance. Conclusions .' These results suggest that the patients of liver cirrhosis with ascites have restrictive ventilatory impairment with additional obstructive ventilatory impairment. After paracentesis, the restrictive ventilatop impairment is improved by the relief of diaphragmatic motion limitation caused by ascites. Also, paracentesis of(not large volume, like 5000ml, but) relatively small volume, of 2000 3000ml can achieve objective improvement of dyspnea due to tense ascites.
  • 3,440 View
  • 25 Download
Efficacy and Safety of Large Volume Paracentesis in Cirrhotic Patients with Spontaneous Bacterial Peritonitis : A Randomized Prospective Study
Chang Hwan Choi, M.D., Kwang-Hyub Han, M.D., Do Young Kim, M.D., Jae Hee Cho, M.D., Jae Youn Cheong, M.D., Kun Hoon Song, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.
Korean J Hepatol 2002;8(1):52-60.
Background/Aims
Large volume paracentesis (LVP) associated with plasma volume expansion is known to be an effective and safe therapy for tense or refractory ascites in cirrhosis. Spontaneous bacterial peritonitis (SBP) is one of the frequent infections in patients with cirrhosis. We conducted a study to assess the efficacy and safety of large volume paracentesis in cirrhotic patients with SBP. Methods: We randomly assigned 40 patients with cirrhosis and SBP to either treatment with LVP (21 patients) or general management (19 patients). LVP was defined as drainage of ascitic fluid of more than 4 liters in a single tap or loss of shifting dullness after paracentesis. LVP was performed within 48 hours after the diagnosis of SBP in the LVP group. Cefotaxime was given daily in doses that varied according to the serum creatinine level in both groups. Albumin was given at a dose of 6-8 g per 1 liter of removed ascites in the LVP group. Results: After seven days of treatments, the blood chemistry test, and WBC (PMN) counts and protein concentration in the ascitic fluid were not different between the two groups. Among them, the WBC (PMN) counts were decreased significantly in both groups and protein concentrations tended to increase. Durations of abdominal tenderness and pain were shorter in the LVP group but the differences were statistically not significant. Admission periods, resolution rates of SBP after seven days of treatment, complication rates and in-hospital mortality rates were not different between the two groups. Conclusions: The two treatment methods demonstrated almost the same effectiveness and safety. The symptoms were improved slightly faster in the LVP group. We concluded that large volume paracentesis is not an absolute contraindication and can be a tolerable and safe therapy in some selected cirrhotic patients with tense ascites and SBP.(Korean J Hepatol 2002;8:52-60)
  • 4,518 View
  • 73 Download